Skip to content

Clinical Application Study of FAPI-FUSCC-07 PET/CT Tumor Imaging

Clinical Application Study of FAPI-FUSCC-07 PET/CT Tumor Imaging

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089492
Enrollment
Unknown
Registered
2024-09-10
Start date
2024-09-13
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Gold Standard:Using pathology or imaging follow-up results as the reference standard

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign the informed consent form. 2. Age = 18 years. 3. Tumor patients highly suspected or diagnosed by gastroscopy or routine imaging examinations. 4. Based on the physician's judgment, an expected survival time of 3 months. 5. Agree to practice strict contraception for at least 28 days after the administration of 18F-FAPI-FUSCC-07. 6. Willing and able to comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women. 2. Unable to lie down on the PET/CT scanning bed or intolerant to PET examination during the scan. 3. Participation in other interventional clinical trials within 1 month prior to screening. 4. Patients who are lost to follow-up. 5. Other conditions that may affect the study or make the subject unsuitable for participation as assessed by the investigator.

Design outcomes

Primary

MeasureTime frame
SUVmax (Standardized Uptake Value max);

Secondary

MeasureTime frame
Tumor-to-background ratios;

Countries

China

Contacts

Public ContactShaoli Song

Fudan University Shanghai Cancer Center

shaoli-song@163.com+86 138 1660 8573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026